On March 26, 2025, the acting USPTO director, Coke Morgan Stewart, published a Memorandum addressed to all judges for the Patent Trial and Appeals Board (PTAB), in which Acting Director Stewart detailed an interim bifurcated...more
On Friday, March 14, 2025, Delaware's own Judge Andrews provided important guidance on key patent issues, relevant to pharmaceutical and technology companies alike: (1) the decisive impact of local patent rules on summary...more
3/25/2025
/ Intellectual Property Protection ,
Litigation Strategies ,
Local Rules ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Risk Management ,
Summary Judgment ,
Technology Sector
Venable has offered general thoughts on the potential fallout from the Supreme Court's reversal of the long-standing Chevron deference, as well as practice area-specific analysis. Here, the Intellectual Property Litigation...more
7/11/2024
/ America Invents Act ,
Chevron Deference ,
Government Agencies ,
Imports ,
International Trade Commission (ITC) ,
Loper Bright Enterprises v Raimondo ,
Patent Infringement ,
Patent Trial and Appeal Board ,
Patents ,
Regulatory Authority ,
SCOTUS ,
Statutory Interpretation ,
USPTO
A recent en banc Federal Circuit decision overruled the unique test for obviousness of design patents and advised that the same analysis should apply to both utility patents and design patents. LKQ Corporation v. GM Global...more